Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report
The American Journal on Addictions · 2023
DOI: 10.1111/ajad.13396 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal on Addictions, 2023. Verfasst von David B Hathaway und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives Patients with opioid use disorder may be asked by their clinicians to discontinue maintenance buprenorphine treatment before surgical operations due to concerns that buprenorphine will interfere with acute pain management. However, discontinuation of buprenorphine may not be well tolerated or safe for all patients. We, therefore, administered a survey to better understand the experiences of patients on buprenorphine treatment who had previously undergone painful procedures and had their buprenorphine maintenance treatment either continued or discontinued before the procedure.
Methods
After this study received institutional review board approval, patients were invited to participate if they were being prescribed sublingual buprenorphine for treatment of opioid use disorder and had also previously undergone a painful procedure requiring treatment with full agonist opioids. Patients who were eligible and agreed to participate ( n = 32) then completed a survey of basic demographics; medical, psychiatric, and substance use histories; and their experience and satisfaction with the treatment of pain and substance use in the perioperative period, including whether buprenorphine was continued or discontinued before their procedure.
Results
Compared with patients whose home dose of buprenorphine was continued ( n = 15), patients whose buprenorphine was discontinued preoperatively ( n = 17) reported less satisfaction with pain management and were more likely to be prescribed full agonist opioids upon discharge. Discussion and Conclusions Consistent with prior studies, these survey findings suggest that discontinuation of buprenorphine before painful surgeries may be associated with poorer clinical outcomes. Scientific Significance This survey study adds patients' perspective to a growing body of scientific literature suggesting that discontinuation of maintenance buprenorphine treatment before painful procedures may decrease patient satisfaction and increase clinical risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: David B Hathaway, Claudia Rodriguez, Joji Suzuki
Zitieren
APA
Hathaway, D. B., Bhat, J. A., Twark, C., Rodriguez, C., & Suzuki, J. (2023). Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report. The American Journal on Addictions. https://doi.org/10.1111/ajad.13396
Vancouver
Hathaway DB, Bhat JA, Twark C, Rodriguez C, Suzuki J. Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report. The American Journal on Addictions. 2023. doi:10.1111/ajad.13396
BibTeX
@article{Hathaway2023,
author = {Hathaway, David B and Bhat, Jasra-Ali and Twark, Claire and Rodriguez, Claudia and Suzuki, Joji},
title = {Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report},
journal = {The American Journal on Addictions},
year = {2023},
doi = {10.1111/ajad.13396}
}
EUVIMED